Ovoca Bio Plc (OVB) Euro 0.125

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Ovoca Bio shares plummet after female libido treatment trial fails
31 August 2023 14:33
(Sharecast News) - Biopharmaceutical developer Ovoca Bio's shares were plummeting on Thursday, after it released a summary of the top-line results from its phase two dose-ranging study evaluating...
-
Ovoca Bio to dispose of Russian assets
8 March 2023 11:45
(Sharecast News) - Biopharmaceutical company Ovoca Bio announced on Wednesday that it will be disposing of certain Russian assets to the private Russian company Desirix.
-
Ovoca Bio enrols participants in women's sexual drug trial
29 July 2022 16:00
(Sharecast News) - Women's health-focussed biopharmaceutical company Ovoca Bio announced the successful completion of participant enrollment in a phase 2 dose-ranging study assessing...
Company announcements Announcements
-
Management Changes
3 March 2025 14:00
Ovoca Bio (CDI)
-
Result of AGM
18 December 2024 18:00
Ovoca Bio (CDI)
-
Notice of AGM
18 November 2024 07:00
Ovoca Bio (CDI)
-
Holding(s) in Company
11 October 2024 17:30
Ovoca Bio (CDI)
-
Sale of Treasury Shares
9 October 2024 17:45
Ovoca Bio (CDI)
-
Half-year Report
25 September 2024 07:00
Ovoca Bio (CDI)
-
Directorate Change
15 July 2024 07:00
Ovoca Bio (CDI)
-
Director/PDMR Shareholding
15 July 2024 07:00
Ovoca Bio (CDI)
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.